Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)

  • In development
  • GID-NG10216
  • Expected publication date: 

Register as a stakeholder

We are updating the osteoporosis guideline to bring all NICE recommendations into one comprehensive resource. The revised guidance will be delivered in two parts:  

Part 1: will cover identifying adults who should be assessed for fragility fracture risk, methods of risk assessment, identifying vertebral fractures, treatment criteria and repeat risk assessment (timing and methods) for people not receiving treatment.

Part 2: will cover risk assessment for people with a learning disability, treatment (pharmacological, exercise and calcium and vitamin D), monitoring of treatment and treatment pauses, incorporating recommendations from a new Multiple Technology Appraisal (MTA) to create a single set of pharmacological treatment guidelines.

The Stakeholder consultation on Part 1  and the consultation on the MTA scope runs from 13 January to 23 February 2026.  

 

Documents

Documents created during the development process.

Draft guidance consultation

Declaration of interests

Stakeholder list updated

Committee list updated

Scope published

Committee meetings

Draft scope consultation